A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Plaque psoriasis is the most common ... There’s no cure for psoriasis, but treatment can help manage your symptoms. If you have mild psoriasis, a doctor may recommend home remedies and over ...

They may recommend treatments to help manage your symptoms ... Ilumya is used to treat mild to severe plaque psoriasis. If this condition affects your scalp, you may experience hair loss due ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Otezla may cause mild side effects other than the ... Otezla is approved for the treatment of moderate to severe plaque psoriasis in children ages 6 years and older. The drug is prescribed for ...

Mild side effects of Skyrizi can include ... They can recommend the right treatment for you. With plaque psoriasis, your immune system mistakenly attacks your body. Skyrizi helps treat plaque ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...

Last December, it secured FDA approval for the treatment of adult patients with plaque psoriasis, regardless of the severity of their symptoms, making it an option for all the estimated eight ...

Opens in a new tab or window ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 weeks of treatment with an investigational ...

Arcutis Biotherapeutics' Zoryve drives revenue growth and nears cash flow positivity, yet high valuation warrants a Hold ...